MED12 overexpression is a frequent event in castration-resistant prostate cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Endocrine-Related Cancer

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/ERC-14-0171PMID 24938407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration‐resistant prostate cancer

  2014cited by this paper
• Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients

  2013cited by this paper
• Functional Studies of the Yeast Med5, Med15 and Med16 Mediator Tail Subunits

  2013cited by this paper
• High‐throughput SNP‐based authentication of human cell lines

  2013cited by this paper
• MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling.

  2012influential reference
• Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle

  2012cited by this paper
• Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.

  2012cited by this paper
• Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

  2012influential reference
• Expression of TGFβ3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase/AKT signaling pathway

  2012influential reference
• Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer

  2011cited by this paper
• Tumor focality in prostate cancer: implications for focal therapy

  2011cited by this paper
• The hedgehog/Gli signaling paradigm in prostate cancer

  2011cited by this paper
• MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

  2011cited by this paper
• The histone variant macroH2A suppresses melanoma progression through regulation of CDK8

  2010cited by this paper
• The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation

  2010influential reference
• Suppression by L-methionine of cell cycle progression in LNCaP and MCF-7 cells but not benign cells.

  2010cited by this paper
• Mediator structural conservation and implications for the regulation mechanism.

  2009cited by this paper
• Silencing of Transforming Growth Factor-β1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo

  2008cited by this paper
• The Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity and Can Function Independently of Mediator

  2008cited by this paper
• Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness

  2007cited by this paper
• Smad3 Is Overexpressed in Advanced Human Prostate Cancer and Necessary for Progressive Growth of Prostate Cancer Cells in Nude Mice

  2007influential reference
• Transforming Growth Factor-β3 Increases the Invasiveness of Endometrial Carcinoma Cells through Phosphatidylinositol 3-Kinase-dependent Up-regulation of X-linked Inhibitor of Apoptosis and Protein Kinase C-dependent Induction of Matrix Metalloproteinase-9*

  2007cited by this paper
• p 27 Kip 1 , a cyclin-Cdk inhibitor , links transforming growth factor-13 and contact inhibition to cell cycle arrest

  2007cited by this paper
• Mediator is a transducer of Wnt/beta-catenin signaling.

  2006cited by this paper
• A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma

  2006cited by this paper
• Mediator Modulates Gli3-Dependent Sonic Hedgehog Signaling

  2006cited by this paper
• Mediator Is a Transducer of Wnt/β-Catenin Signaling*

  2006cited by this paper
• p21Cip1 and p27Kip1 Induce Distinct Cell Cycle Effects and Differentiation Programs in Myeloid Leukemia Cells*

  2005cited by this paper
• TGF-beta and epithelial-to-mesenchymal transitions.

  2005cited by this paper
• Wnt signalling and prostate cancer

  2005cited by this paper
• Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).

  2005cited by this paper
• Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice

  2004cited by this paper
• Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase

  2003cited by this paper
• The -Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells

  2002cited by this paper
• The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

  2002cited by this paper
• Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.

  2002cited by this paper
• Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines

  2002cited by this paper
• Prostate Cancer Mitogen-activated Protein Kinase Signaling Pathway in Human Effect by Oncogenic HaRas-induced Activation of the 1 β Mitogenic Conversion of Transforming Growth Factor-Updated

  2000cited by this paper
• Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.

  2000cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Transforming growth factor-â 1 upregulates p 15 , p 21 and p 27 and blocks cell cycling in G 1 in human prostate epithelium

  1999cited by this paper
• Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium.

  1999cited by this paper
• Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.

  1999cited by this paper
• Prostate Epithelial Cells Induces Malignant Transformation of Nontumorigenic Rat β Loss of Responsiveness to Transforming Growth Factor Updated

  1999influential reference
• Insensitivity to growth inhibition by TGF-β1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells

  1998cited by this paper
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

  1994cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper

• Epigenetic regulation of MED12: a key contributor to the leukemic chromatin landscape and transcriptional dysregulation

  2025cites this paper
• Immunoexpression of MED12 in lobular carcinoma in situ confined within fibroadenoma of breast

  2025cites this paper
• The Mediator Complex: A Regulatory Hub for Transcriptional Activity of Nuclear Receptors

  2025cites this paper
• The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer

  2025cites this paper
• A Novel Prognostic Risk‐Scoring Model Based on RAS Gene‐Associated Cluster in Pediatric Acute Myeloid Leukemia

  2025cites this paper
• MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer

  2024cites this paper
• MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer

  2024influential citation
• Prognostic Values of Gene Copy Number Alterations in Prostate Cancer

  2023cites this paper
• Integrative Study of Phytochemicals for Anti-Fibroid Agent: A Perspective on Protein Networks, Molecular Docking, ADMET, Simulation, DFT and Bioactivity

  2023cites this paper
• Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)

  2023cites this paper
• Exosomal transfer of miR-548aq-3p confers cisplatin resistance via MED12 downregulation in epithelial ovarian cancer.

  2023cites this paper
• Rewiring of miRNA-mRNA bipartite co-expression network as a novel way to understand the prostate cancer related players

  2023cites this paper
• The role of mediator subunit 12 in tumorigenesis and cancer therapeutics

  2022cites this paper
• DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective

  2022cites this paper
• Prospective study on association of 25-hydroxy vitamin D3 and uterne fibroid

  2022cites this paper
• Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma.

  2022cites this paper
• Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMT

  2022cites this paper
• Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait

  2022cites this paper
• MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axis

  2022cites this paper
• Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression-based convolutional neural networks

  2021cites this paper
• MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase.

  2021cites this paper
• Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases

  2020cites this paper
• Molecular pathology of prostate cancer: a practical approach.

  2020cites this paper
• Mediator's Kinase Module: A Modular Regulator of Cell Fate

  2020cites this paper
• Introduction of Somatic Mutation in MED12 Induces Wnt4/β-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell

  2020cites this paper
• The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics

  2019cites this paper
• MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC

  2019cites this paper
• Major Candidate Genes Associated with Risk of Hereditary and Sporadic Prostate Cancer

  2019cites this paper
• Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR.

  2018cites this paper
• Overexpression of p54nrb/NONO induces differential EPHA6 splicing and contributes to castration-resistant prostate cancer growth

  2018cites this paper
• Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories

  2017cites this paper
• Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer

  2017cites this paper
• The mediator complex in genomic and non‐genomic signaling in cancer

  2017cites this paper
• Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer

  2016cites this paper
• Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/&bgr;-Catenin Signaling Pathway

  2016cites this paper
• Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms

  2016cites this paper
• Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells.

  2016cites this paper
• THE ROLE OF MED 12 IN TUMORIGENESIS

  2016cites this paper
• Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker

  2016cites this paper
• Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients

  2016cites this paper
• Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer.

  2015cites this paper
• Mediator kinase module and human tumorigenesis

  2015influential citation